Ta-Ken Biomedical Announces Ex-Dividend Date for Q1 2026 Cash Dividend

1. Date of Board, Shareholders' Meeting Resolution or Company Decision: 08/14/2026 2. Type of Rights/Dividend (please enter 'Rights', 'Dividend' or 'Rights & Dividend'): Dividend 3. Ordinary Share Dividend Type and Amount: Cash Dividend: NT$93,919,552, distributed at NT$0.11658854 per share 4. Ex-Rights/Dividend Trading Day: 09/03/2026 5. Last Transfer Date: 09/04/2026 6. Start Date of Transfer Suspension: 09/05/2026 7. End Date of Transfer Suspension: 09/09/2026 8. Ex-Rights/Dividend Benchmark Date: 09/09/2026 9. Final Application Date for Bond Conversion: None 10. Start Date of Bond Conversion Suspension: None 11. End Date of Bond Conversion Suspension: None 12. Ordinary Share Cash Dividend Payment Date: 10/08/2026 13. Is Part or All of the Cash Dividend Paid in Foreign Currency (please enter 'Yes' or 'No'): No 14. Currency for Foreign Cash Dividend: None 15. Recipients of Foreign Cash Dividend: None 16. Exchange Rate Determination Method for Foreign Cash Dividend: None 17. Other Matters to be Disclosed: None